Clinical trial
Rosiglitazone And Plaque Study for Type 2 Diabetes Mellitus
NCT00231387 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00231387 |
|---|---|
| Title | Rosiglitazone And Plaque Study for Type 2 Diabetes Mellitus |
| Official title | Rosiglitazone and Plaque Study: A 12 Month Randomised, Double-blind, Placebo-controlled, Magnetic Resonance Imaging Study to Evaluate the Effect of Rosiglitazone on the Structure and Composition of Carotid Atherosclerotic Plaques in Subjects With Type 2 Diabetes Mellitus and Coexisting Vascular… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-insulin-dependent Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | rosiglitazone |
| Enrollment | 60 |
| Start date | Sep 1, 2002 |
| Primary completion | May 1, 2005 |
| Completion | May 1, 2005 |
| First posted | Oct 4, 2005 |
| Last update posted | Jan 23, 2017 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: